These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 33651311)
1. LncRNA HOXC-AS3 Suppresses the Formation of Mature miR-96 in Ovarian Cancer Cells to Promote Cell Proliferation. Yang B; Sun L; Liang L Reprod Sci; 2021 Aug; 28(8):2342-2349. PubMed ID: 33651311 [TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXC-AS3 increases non-small cell lung cancer cell migration and invasion by sponging premature miR-96. Wan L; Cheng Z; Sun Q; Jiang K Expert Rev Respir Med; 2022 May; 16(5):587-593. PubMed ID: 35034519 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway. Zhao R; Song J; Jin Y; Liu Y J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789 [TBL] [Abstract][Full Text] [Related]
5. A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis. Shi SH; Jiang J; Zhang W; Sun L; Li XJ; Li C; Ge QD; Zhuang ZG Cancer Invest; 2020 Jan; 38(1):1-12. PubMed ID: 31797701 [No Abstract] [Full Text] [Related]
6. LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B. Li J; Hou F; Teng Z; Xia W; Peng J J Cancer Res Clin Oncol; 2024 Jun; 150(6):294. PubMed ID: 38842683 [TBL] [Abstract][Full Text] [Related]
7. Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer. Zhu W; Chen X; Guo X; Liu H; Ma R; Wang Y; Liang Y; Sun Y; Wang M; Zhao R; Gao P Cancer Res; 2022 Mar; 82(5):805-818. PubMed ID: 35031573 [TBL] [Abstract][Full Text] [Related]
8. LncRNA OIP5-AS1 upregulates snail expression by sponging miR-34a to promote ovarian carcinoma cell invasion and migration. Jiang X; Ye Z; Jiang Y; Yu W; Fang Q Biol Res; 2020 Oct; 53(1):49. PubMed ID: 33092644 [TBL] [Abstract][Full Text] [Related]
9. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer. Hao T; Huang S; Han F Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404 [TBL] [Abstract][Full Text] [Related]
10. LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25. Sui Y; Chi W; Feng L; Jiang J BMC Pulm Med; 2020 Mar; 20(1):59. PubMed ID: 32138716 [TBL] [Abstract][Full Text] [Related]
11. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Zhang E; He X; Zhang C; Su J; Lu X; Si X; Chen J; Yin D; Han L; De W Genome Biol; 2018 Oct; 19(1):154. PubMed ID: 30286788 [TBL] [Abstract][Full Text] [Related]
12. SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells. Shi Z; Zhang H; Shen Y; Zhang S; Zhang X; Xu Y; Sun D Thorac Cancer; 2023 Sep; 14(25):2579-2590. PubMed ID: 37548102 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis. Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064 [TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1. Su H; Fan G; Huang J; Qiu X Cell Death Dis; 2022 Apr; 13(4):307. PubMed ID: 35387975 [TBL] [Abstract][Full Text] [Related]
15. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b. Chai Y; Wang L; Qu Y; Hu Z J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HOXC-AS3 facilitates the progression of invasive mucinous adenocarcinomas of the lung via modulating FUS/FOXM1. Yang Z; Hu T In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):15-23. PubMed ID: 31925650 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis. Yang X; Xin N; Qu HJ; Wei L; Han Z Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662 [TBL] [Abstract][Full Text] [Related]
18. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR. Wang L; Yu M; Zhao S J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer. Li W; Ma S; Bai X; Pan W; Ai L; Tan W J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170 [TBL] [Abstract][Full Text] [Related]
20. LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer. Zhu D; Huang X; Liang F; Zhao L J Ovarian Res; 2020 Jan; 13(1):3. PubMed ID: 31907059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]